Comment on 'KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study'
Date
2017
Authors
Hughes, A.E.
Clarson, J.
Gargett, T.
Yu, W.
Brown, M.P.
Lopez, A.F.
Hughes, T.P.
Yong, A.S.M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Leukemia Research, 2017; 55:55-57
Statement of Responsibility
Conference Name
Abstract
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2017 Elsevier